SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-046992
Filing Date
2021-09-02
Accepted
2021-09-02 17:00:54
Documents
14
Period of Report
2021-08-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-8k_20210830.htm   iXBRL 8-K 50303
2 EX-99.1 crnx-ex991_15.htm EX-99.1 10803
3 GRAPHIC gyyxrejcryub000001.jpg GRAPHIC 20636
  Complete submission text file 0001564590-21-046992.txt   228743

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA crnx-20210830.xsd EX-101.SCH 5689
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20210830_lab.xml EX-101.LAB 20075
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20210830_pre.xml EX-101.PRE 11939
7 EXTRACTED XBRL INSTANCE DOCUMENT crnx-8k_20210830_htm.xml XML 3689
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 211234026
SIC: 2834 Pharmaceutical Preparations